hydroxychloroquine has been researched along with Asthenia in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man with a history of ischemic-labeled heart disease revealed by conduction disorders and cutaneous lupus treated initially with hydroxychloroquine followed by chloroquine consulted for asthenia and weight loss." | 3.96 | [A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials]. ( Costedoat-Chalumeau, N; Dion, J; Lenfant, T; Maisonobe, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenfant, T | 1 |
| Dion, J | 1 |
| Maisonobe, T | 1 |
| Costedoat-Chalumeau, N | 1 |
1 other study available for hydroxychloroquine and Asthenia
| Article | Year |
|---|---|
[A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials].
Topics: Antimalarials; Asthenia; Biopsy; Cardiotoxicity; Diagnosis, Differential; Humans; Hydroxychloroquine | 2020 |